Acknowledgements
Professor Finn Boerlum Kristensen, PhD, MD, Danish Centre for Health Economics, University of Southern Denmark, Denmark
Professor, Laura Pizzi, PhD, Rutgers University, Ernest Mario School of Pharmacy, NJ, USA
Karen Worley, MS, PhD, Director, Humana Healthcare, OH, USA
Bruce Gingles, Cook Medical, IN, USA
James F Murray, PhD, Research Fellow, Eli Lilly and Company, IN, USA
Carla Zema, PhD, Zema Consulting, AL, USA
Authors & Contributors
Authors:
Patrick LaFontaine, Associate Director, Global HEOR, Oncology, Sanofi, NJ, USA
Daryl S. Spinner, PhD MBA, BS, VP, Market Access & Reimbursement, Variantyx, Inc., NC, USA
Contributors:
Kelly Lenahan, MPH, Manager, Scientific and Health Policy Initiatives, ISPOR
John Guerino, MHS, Manager, Scientific and Health Policy Initiatives, ISPOR
Theresa Tesoro, MSN, Associate Director, Scientific and Health Policy Initiatives, ISPOR